⌘K

Login Start Free

Home/Filings/4/0001213900-25-106836

4//SEC Filing

Shenouda Maged 4

Accession 0001213900-25-106836

CIK 0001553643other

View on SEC.gov Company Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 7:30 AM ET

Size

4.6 KB

Accession

0001213900-25-106836

Insider Transaction Report

Form 4

Period: 2025-11-05

RELMADA THERAPEUTICS, INC.RLMD

Chief Financial Officer

Transactions

Purchase
Common Stock
2025-11-05$2.20/sh+500,000$1,100,000→ 788,335 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1

filerCIK 0001658369

Filing Metadata

Form type: 4
Filed: Nov 5, 7:00 PM ET
Accepted: Nov 6, 7:30 AM ET
Size: 4.6 KB

View on SEC.gov